TY - JOUR T1 - Protocol for process evaluation of CIVIC randomised controlled trial: Community-based InterVentions to prevent serIous Complications following spinal cord injury in Bangladesh JF - BMJ Open JO - BMJ Open DO - 10.1136/bmjopen-2018-024226 VL - 8 IS - 7 SP - e024226 AU - Mohammad Sohrab Hossain AU - Lisa A Harvey AU - Hueiming Liu AU - Md. Shofiqul Islam AU - Md. Akhlasur Rahman AU - Stephen Muldoon AU - Fin Biering-Sorensen AU - Ian D Cameron AU - Harvinder S Chhabra AU - Richard I Lindley AU - Stephen Jan Y1 - 2018/07/01 UR - http://bmjopen.bmj.com/content/8/7/e024226.abstract N2 - Introduction People with spinal cord injuries in low-income and middle-income countries are highly vulnerable to life-threatening complications in the period immediately after discharge from hospital. We are conducting a randomised controlled trial in Bangladesh to determine whether all-cause mortality at 2 years can be reduced if health professionals regularly ring and visit participants in their homes following discharge. We will conduct a process evaluation alongside the trial to explain the trial results and determine the feasibility of scaling this intervention up in low-income and middle-income countries if it is found to be effective.Methods and analysis Our process evaluation is based on the Realist and Reach, Effectiveness, Adoption, Implementation and Maintenance frameworks. We will use a mixed methods approach that uses both qualitative and quantitative data. For example, we will audit a sample of telephone interactions between intervention participants and the healthcare professionals, and we will conduct semistructured interviews with people reflective of various interest groups. Quantitative data will also be collected to determine the number and length of interactions between the healthcare professionals and participants, the types of issues identified during each interaction and the nature of the support and advice provided by the healthcare professionals. All quantitative and qualitative data will be analysed iteratively before the final analysis of the trial results. These data will then be triangulated with the final results of the primary outcome.Ethics and dissemination Ethics approval was obtained from the institutional ethics committee at the site in Bangladesh and from the University of Sydney, Australia. The study will be conducted in compliance with all stipulations of its protocol, the conditions of ethics committee approval and the relevant regulatory bodies. The results of the trial will be disseminated through publications in peer-reviewed scientific journals and presentations at scientific conferences.Trial registration number ACTRN12615000630516. ER -